Class II Recall

Ajanta Pharma USA Inc

Product
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
Reason
Failed Dissolution Specifications: below specification
Classification
Class II
Status
Ongoing
Lot
Lot: DJ25134, Exp 11/30/2028
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Ajanta Pharma USA Inc — Class II Recall | MedicineWatch US